Breaking News Instant updates and real-time market news.

SHSP

SharpSpring

$15.42 /

+1.07 (+7.46%)

07:52
11/17/20
11/17
07:52
11/17/20
07:52

SharpSpring price target raised to $18 from $14 at Canaccord

Canaccord analyst David Hynes raised the firm's price target on SharpSpring to $18 from $14 and keeps a Buy rating on the shares. The analyst noted the company laid out a framework for how the business and financial model should evolve over time. It said net revenue retention should evolve over time, the firm's newer cohorts are already outperforming the old, unit economics should scale and be profitable, and potential revenue growth of 25-35% through 2025.

  • 17

    Nov

SHSP SharpSpring
$15.42 /

+1.07 (+7.46%)

08/14/20 Roth Capital
SharpSpring price target raised to $15 from $12 at Roth Capital
07/22/20 Roth Capital
SharpSpring price target lowered to $12 from $14 at Roth Capital
04/15/20 Craig-Hallum
SharpSpring assumed with a Buy at Craig-Hallum
03/13/20 Lake Street
SharpSpring price target lowered to $14 from $17 at Lake Street

TODAY'S FREE FLY STORIES

Conference/Events
Jefferies investment analysts to hold analyst/industry conference call » 16:25
02/25/21
02/25
16:25
02/25/21
16:25

Investment Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Quaker Houghton sees FY21 adjusted EBITDA up over 20% vs. $222M in FY20  16:24
02/25/21
02/25
16:24
02/25/21
16:24
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

 
ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

Downgrade
Verra Mobility downgraded to Equal Weight from Overweight at Morgan Stanley » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
VRRM

Verra Mobility

$14.15 /

-0.75 (-5.03%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

02/12/21 BTIG
Verra Mobility price target raised to $18 from $15 at BTIG
01/22/21 William Blair
Verra Mobility acquisition should drive 15% share upside, says William Blair
11/24/20 BTIG
Verra Mobility price target raised to $15 from $13 at BTIG
11/23/20 Deutsche Bank
Verra Mobility price target raised to $13 from $12 at Deutsche Bank
VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

VRRM Verra Mobility
$14.15 /

-0.75 (-5.03%)

Hot Stocks
Clearwater Paper: Demand for tissue products to be 'volatile' due to Covid-19 » 16:24
02/25/21
02/25
16:24
02/25/21
16:24
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

"For the first…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

Earnings
Dicerna reports FY20 EPS ($1.52), consensus ($1.05) » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
DRNA

Dicerna

$28.14 /

+0.11 (+0.39%)

Reports FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
DRNA Dicerna
$28.14 /

+0.11 (+0.39%)

Hot Stocks
Evolent Health's Evolent Care Partners network adds two physician groups » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Evolent Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

Earnings
Quaker Houghton reports Q4 adjusted EPS $1.63, consensus $1.52 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

Earnings
Collegium Pharmaceutical reports Q4 EPS 20c, consensus 29c » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
COLL

Collegium Pharmaceutical

$26.04 /

-0.16 (-0.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

01/11/21 H.C. Wainwright
Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
COLL Collegium Pharmaceutical
$26.04 /

-0.16 (-0.61%)

Earnings
Clearwater Paper reports Q4 adjusted EPS $1.45 consensus $1.53 » 16:23
02/25/21
02/25
16:23
02/25/21
16:23
CLW

Clearwater Paper

$41.77 /

-1.305 (-3.03%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

01/21/21 BMO Capital
Clearwater Paper initiated with an Outperform at BMO Capital
05/07/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform at RBC Capital on 'clear tailwinds'
05/06/20 RBC Capital
Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

CLW Clearwater Paper
$41.77 /

-1.305 (-3.03%)

Conference/Events
UBS restaurants analyst to hold analyst/industry conference call » 16:22
02/25/21
02/25
16:22
02/25/21
16:22

Restaurants Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Quaker Houghton CEO Michael Barry to retire » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
KWR

Quaker Houghton

$296.40 /

+1.4 (+0.47%)

Quaker Houghton announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

12/21/20 Sidoti
Quaker Houghton reinstated with a Neutral at Sidoti
12/11/20 Deutsche Bank
Quaker Houghton initiated with a Buy at Deutsche Bank
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
05/13/20 Janney Montgomery Scott
Quaker Houghton downgraded to Neutral from Buy at Janney Montgomery Scott
KWR Quaker Houghton
$296.40 /

+1.4 (+0.47%)

Earnings
Floor & Decor reports Q4 EPS 54c, consensus 44c » 16:22
02/25/21
02/25
16:22
02/25/21
16:22
FND

Floor & Decor

$93.93 /

-3.605 (-3.70%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

02/19/21
Fly Intel: Top five analyst upgrades
02/19/21 Piper Sandler
Floor & Decor upgraded to Overweight from Neutral at Piper Sandler
02/09/21 Wells Fargo
Floor & Decor price target raised to $120 from $105 at Wells Fargo
01/28/21 Telsey Advisory
Floor & Decor upgraded to Outperform from Market Perform at Telsey Advisory
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

  • 11
    Aug
  • 20
    May
FND Floor & Decor
$93.93 /

-3.605 (-3.70%)

Hot Stocks
Eventbrite sees modest pace of recovery in paid ticket volume, revenue in 1H » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EB

Eventbrite

$19.04 /

-1.82 (-8.72%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

Earnings
Eargo sees FY21 revenue $87M-$93M, consensus $87.73M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Sees FY21 fross margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

EAR Eargo
$61.13 /

-3.855 (-5.93%)

Earnings
Evolent Health sees Q1 revenue $205M-$215M, consensus $229.29M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

Earnings
Eventbrite reports Q4 EPS (22c) consensus (37c) » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EB

Eventbrite

$19.04 /

-1.82 (-8.72%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

12/16/20 JPMorgan
Eventbrite price target raised to $15 from $10 at JPMorgan
05/18/20
Fly Intel: Top five analyst upgrades
05/18/20 SunTrust
Eventbrite upgraded to Buy at SunTrust on valuation
05/18/20 SunTrust
Eventbrite upgraded to Buy from Hold at SunTrust
EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

EB Eventbrite
$19.04 /

-1.82 (-8.72%)

Earnings
BeiGene reports Q4 EPS ($5.20), consensus ($4.81) » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
BGNE

BeiGene

$330.07 /

-7.12 (-2.11%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

02/18/21 Cowen
BeiGene price target raised to $429 from $348 at Cowen
01/12/21 Piper Sandler
BeiGene price target raised to $190 from $185 at Piper Sandler
12/29/20 Piper Sandler
BeiGene NRDL inclusions 'absolutely critical,' says Piper Sandler
12/08/20 Ladenburg
Ladenburg upgrades BeiGene to Buy after product approvals, ASH data
BGNE BeiGene
$330.07 /

-7.12 (-2.11%)

  • 02
    Dec
Earnings
Evolent Health sees 2021 revenue $830M-$880M, consensus $940.38M » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Adjusted EBITDA is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

Earnings
BioMarin sees FY21 revenue $1.75B-$1.85B, consensus $1.91B » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
BMRN

BioMarin

$81.86 /

-1.48 (-1.78%)

Sees FY21 GAAP net loss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/11/21 Baird
BioMarin price target raised to $110 from $100 at Baird
12/21/20 Piper Sandler
BioMarin data today should ease approvability concerns, says Piper Sandler
12/17/20 JPMorgan
BioMarin remains 'highest conviction name' at JPMorgan
BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

BMRN BioMarin
$81.86 /

-1.48 (-1.78%)

Earnings
Universal Health sees FY21 adjusted EPS $10.05-$11.05, consensus $10.75 » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
UHS

Universal Health

$135.04 /

-2.825 (-2.05%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

UHS Universal Health
$135.04 /

-2.825 (-2.05%)

01/05/21 Deutsche Bank
Universal Health price target raised to $145 from $135 at Deutsche Bank
01/05/21 BofA
BofA sees tailwinds for healthcare facilities, names HCA Healthcare top pick
01/05/21 BofA
Universal Health downgraded to Underperform from Neutral at BofA
12/18/20 Mizuho
Universal Health price target raised to $151 from $130 at Mizuho
UHS Universal Health
$135.04 /

-2.825 (-2.05%)

UHS Universal Health
$135.04 /

-2.825 (-2.05%)

UHS Universal Health
$135.04 /

-2.825 (-2.05%)

Options
Closing CBOE SPX and VIX Index summary for February 25th » 16:20
02/25/21
02/25
16:20
02/25/21
16:20
VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

Earnings
Eargo reports Q4 EPS (30c), consensus (21c) » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

EAR Eargo
$61.13 /

-3.855 (-5.93%)

Hot Stocks
iHeartMedia announces new operating structure » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
IHRT

iHeartMedia

$13.66 /

-0.82 (-5.66%)

The company says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

01/19/21 Wells Fargo
iHeartMedia price target raised to $20 from $14 at Wells Fargo
12/18/20 BofA
iHeartMedia cut to Underperform at BofA on low visibility in ad trends
12/18/20 BofA
iHeartMedia downgraded to Underperform from Neutral at BofA
07/24/20 B. Riley FBR
iHeartMedia price target raised to $11 from $8.50 at B. Riley FBR
IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

IHRT iHeartMedia
$13.66 /

-0.82 (-5.66%)

Earnings
Evolent Health reports Q4 adjusted EPS (1c), consensus (5c) » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
EVH

Evolent Health

$19.71 /

-1.115 (-5.35%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

01/19/21 Piper Sandler
Evolent Health price target raised to $25 from $15 at Piper Sandler
01/07/21 Canaccord
Evolent Health price target raised to $20 from $16 at Canaccord
01/06/21 BTIG
Evolent Health initiated with a Buy at BTIG
11/06/20 Piper Sandler
Evolent Health price target lowered to $15 from $16 at Piper Sandler
EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

EVH Evolent Health
$19.71 /

-1.115 (-5.35%)

Earnings
Monster Beverage reports Q4 ex-items EPS 62c, consensus 62c » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
MNST

Monster Beverage

$85.42 /

-2.87 (-3.25%)

Reports Q4 revenue $1.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

01/19/21 Bernstein
Monster Beverage initiated with a Market Perform at Bernstein
01/15/21 Truist
Monster Beverage price target raised to $105 from $95 at Truist
01/15/21 Deutsche Bank
Monster Beverage price target raised to $102 from $99 at Deutsche Bank
01/15/21 Citi
Monster Beverage price target raised to $99 from $89 at Citi
MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

MNST Monster Beverage
$85.42 /

-2.87 (-3.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.